Tarsus Pharmaceuticals, Inc. (TARS)

Healthcare · Biotechnology · NASDAQ

Tarsus Pharmaceuticals, Inc. (TARS) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $3.61B and a free-cash-flow yield of -0.7%. Over the most recent reported fiscal year, revenue grew 146.7%.

Market cap	$3.61B
Trailing P/E	—
FCF yield	-0.7%
Revenue growth (YoY)	+146.7%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live TARS data on Nama Insights →